Scandion Oncology (SCOL)

Scandion is a biotechnology company. The company develops pharmaceuticals for the treatment of cancer containing drug-resistant cell clones. The leading product of the company, SCO-101, has shown to improve the effect of certain standard cancer treatments during preclinical studies. The head office of the company is located in Copenhagen.

Quotes for Scandion Oncology

Right Now

+/-: 6.2
%: 18,73%
Latest: 39.3
High: 40.4
Low: 34
Volume: 207 629
Turnover (SEK): 7 716 428
Value (MSEK): 842,0

Board

CEO

Bo Rode Hansen

Chairman Of The Board

Peter Høngaard

Board

Annie Rasmussen
Bo Hansen
Carl Borrebäck
Christian Vinding Thomsen
Jørgen Bardenfleth
Thomas Feldthus

Articles of association

News

2020-10-09 15:12:22 Scandion Oncology announces that the warrant exercise is registered at the Danish Companies Registration Office
2020-10-07 13:46:54 Scandion Oncology announces modified timelines for clinical studies
2020-10-06 09:05:44 Scandion Oncology receives approximately MSEK 12.3 through successful warrant exercise
2020-10-03 11:24:26 Scandion Oncology announces that it has been selected for the final round of MATWIN presentations
2020-10-02 20:05:12 Communique from the Extraordinary General Meeting of Scandion Oncology A/S

News agencies

2020-10-09 15:12:28 Ritzau: Scandion Oncology announces that the warrant exercise is registered at the Danish Companies Registration Office
2020-10-08 12:24:25 Finwire: Anledningen till försening var att sjuksköterskor hade flyttats över till annan avdelning - Scandion
2020-10-07 14:35:23 Finwire: Känner inte till några specifika konkurrenter för SCO-101 - Scandion Oncologys forskningschef
2020-10-07 14:09:49 Finwire: Scandion Oncologys doseskaleringsdel inom kolorektal cancer försenas till andra kvartalet 2021
2020-10-07 13:50:21 Ritzau: Scandion Oncology announces modified timelines for clinical studies

Analysis

2018-10-09 SvD Börsplus: Svår att motstå?

Videos

Largest Owners

Name	Capital %	Votes %	Date
Saniona AB	9,99	9,99	2020-07-31
Jan Stenvang	7,30	7,30	2020-03-31
Avanza Pension	5,71	5,71	2020-03-31
Nils Brünner	5,70	5,70	2020-10-01

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Scandion Oncology

Quotes for Scandion Oncology

Right Now

Board

News

News agencies

Analysis

Videos

Bolagspresentation 25/6

Scandion Oncology från Öresundsdagen 20 maj

Scandion Oncology A/S - Company presentation

Scandion Oncology - Sedermeradagen i Malmö 2018

Largest Owners

Insider trading

Key Numbers

Upcoming reports

Annual reports, prospectus etc.

Technical analysis

SCOL- 2019-03-07

Technical analysis

SCOL- 2019-01-07